Next Article in Journal
Shamanism and Psychoactives: Theory, Practice and Paradoxes of a Field Study in India
Previous Article in Journal
Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Protocol

The Use, Role, and Function of Music During Psychedelic-Assisted Therapy (PAT) with Ayahuasca: A Scoping Review Protocol

by
Guillermo Escobar-Cornejo
1,
Fernando P. Cardenas
1,
Diego Torres
2,
Mario Valderrama
3 and
Mark Ettenberger
4,*
1
Laboratory of Neuroscience and Behavior, Department of Psychology, Universidad de Los Andes, Bogotá 111711, Colombia
2
Casa Elemental, La Calera 251207, Colombia
3
Department of Biomedical Engineering, Universidad de Los Andes, Bogotá 111711, Colombia
4
SONO—Centro de Musicoterapia, Bogotá 110221, Colombia
*
Author to whom correspondence should be addressed.
Psychoactives 2025, 4(2), 9; https://doi.org/10.3390/psychoactives4020009
Submission received: 15 January 2025 / Revised: 6 March 2025 / Accepted: 20 March 2025 / Published: 1 April 2025

Abstract

:
Objective: To provide a state of the art on the use, role, and function of music during psychedelic-assisted therapy (PAT) with ayahuasca. Introduction: Ayahuasca is a medicinal brew with psychoactive qualities used by indigenous communities throughout the Amazon region, and music is deemed crucial during ayahuasca experiences. In PAT, music forms part of the set and setting, but it lacks systematization and is poorly explored in the scientific literature. Inclusion criteria: Published literature in English, Spanish, and Portuguese, focusing on conceptualizing, defining, or describing the use, role, and/or function of music in PAT sessions with ayahuasca. Methods: This review follows the JBI methodology for scoping reviews. We will search Web of Science, Scopus, Google Scholar, and PubMed databases without year restrictions, and a hand search of articles will be performed. Two reviewers will assess titles/abstracts, followed by independent reviews of included full texts. An Excel data extraction sheet will be used to tabulate the information. The findings will be presented narratively, including respective tables or figures. If feasible, a potential theoretical framework for the use, role, and function of music during PAT with ayahuasca will be outlined, including implications for future research and clinical practice.

1. Introduction

Psychedelics are one of the oldest known pharmacological agents used by humans and have been utilized by many cultures for thousands of years [1]. Modern psychedelic therapy emerged in the 1950s with the discovery of lysergic acid diethylamide (LSD) in 1938 and psilocybin in 1955 to treat mental health conditions [2]. However, in the early 1970s, several countries implemented policies that prohibited, restricted, or regulated the use of psychedelics [3]. Over the last decade, psychedelic-assisted therapy (PAT) has experienced a resurgence, particularly by demonstrating its potential for individuals with treatment-resistant depression, anxiety, and addiction disorders [4,5,6,7]. PAT is described as “an emerging therapeutic approach that combines the use of psychedelics (a subclass of hallucinogenic drugs) and psychotherapy…” ([8], p. 1). In PAT, the use of psychedelics is usually embedded in preparatory and integration sessions and accompanied by trained therapists [9]. While different (psycho-)therapeutic models exist within PAT settings, common core elements include a focus on individual and contextual factors (i.e., set and setting), the beforementioned structure of preparation, intake, and integration, and a focus on the inward-directed experience during the psychedelic intake [10].
Ayahuasca, a medicinal brew with psychedelic qualities from the Amazon region, is currently used in PAT studies. Ayahuasca is primarily made from two plants: one is Psychotria viridis (also known as ‘chacruna’), or Diplopterys cabrerana (also known as ‘chagropanga’). Both contain the psychoactive compound dimethyltryptamine (DMT). The second plant is Banisteriopsis caapi, commonly known as ‘ayahuasca’, which contains monoamine oxidase (MAO) inhibitors that prevent the degradation of DMT when orally ingested and allow for 5-HT2A receptor agonism in the central nervous system [11]. The effects of ayahuasca last approximately 4 to 6 h depending on the dosage, and participants can experience altered sensory perception, visions, and a physical purgative effect that may include nausea, vomiting, or diarrhea [12,13].
Ayahuasca has a deep and complex spiritual meaning for indigenous communities and forms part of their cultural heritage for hundreds, if not thousands, of years [14,15]. The first written records of ayahuasca date back to the mid-19th century, when British botanist Richard Spruce observed Tukano indigenous people in Brazil consuming ayahuasca, and Ecuadorian geographer Manuel Villavicencio wrote about its use in the Napo River region [16,17]. In the 1920s, Brazilian churches began using ayahuasca as part of their religious ceremonies, and currently, three of them use ayahuasca as their main sacrament: Santo Daime, União do Vegetal, and Barquinha. At the end of the 1980s, these churches were established internationally, including in Germany, Spain, the Netherlands, Canada, Mexico, and the USA, as well as countries in Africa, Asia, and Central America [18]. Today, ayahuasca is globally consumed in a variety of contexts and settings. A recent report by the International Center for Ethnobotanical Education, Research, and Service (ICEERS) estimates that around 800,000 people consumed ayahuasca in 2019 across the Americas, Europe, Australia, and New Zealand [19].

1.1. The Role of Music

In addition to scientific advances regarding the psycho-pharmacological effects of psychedelics, growing attention is now given to individual and contextual factors that are being considered fundamental in shaping and integrating psychedelic experiences, often referred to as set and setting [20]. In PAT, music forms part of such factors, and the importance of music’s therapeutic function in this context is regularly highlighted [21]. A common ground is the belief that music plays a significant role in enriching and enhancing the psychedelic experience, creates meaning, and facilitates emotionality and mental imagery, contributing in this way to a better therapeutic utilization of psychedelic substances [22,23]. Particularly music’s role and effectiveness in emotion regulation have been discussed in many studies [24,25], with neuronal correlates being found in both cortical and subcortical systems and networks [26]. In PAT, facilitating and regulating emotional states is an important feature in which music can play a crucial role (for an overview, see [23,24]). Such potential benefits of music during psychedelic experiences are certainly not exclusive to PAT. In the case of ayahuasca, singing icaros (i.e., medicine songs) is for example essential for the healing process in traditional ayahuasca ceremonies led by curanderos (i.e., healers) [27], and music is used for enhancing religious ecstasy and facilitating spiritual transcendence in the Santo Daime religion [28,29].
Recent review articles emphasize the interplay of music and psychedelics from a neuroscientific point of view, taking ayahuasca in ceremonial or entheogenic settings as examples [30,31]. Individual studies report on the general role of music during ayahuasca experiences [32], on the relation between musical structures and the religious aspects of ayahuasca rituals in the beforementioned Brazilian churches [33], or on specific aspects such as the time perception of ayahuasca participants when listening to different types of music and sounds [34]. The experiences of listening to icaros have been investigated in both healthy adults [35] and in therapeutic settings, for example, in addiction rehabilitation patients [36].
While there is a breadth of literature on music and ayahuasca in ceremonial and entheogenic contexts, its role in PAT is still poorly explored. This scoping review aims to fill this knowledge gap by specifically looking into the use, role, and function of music during PAT with ayahuasca. Conducting a preliminary database search in MEDLINE, Scopus, the Cochrane Database of Systematic Reviews, and JBI Evidence Synthesis, no scoping reviews were identified on the use, role, and/or function of music during psychedelic therapy with ayahuasca. We consider a scoping review most suitable for the exploration of this topic due to the complex and interdisciplinary nature of the subject. This type of review allows for a broad and inclusive examination of the existing literature, enabling the mapping of various aspects of the music itself. This review will be conducted in an inductive, data-driven manner, in which the conclusions will be primarily informed by the analysis and interpretation of the extracted data of the included studies [37,38].
The main objective of this scoping review is to understand and systematize how, why, and for what goals music is used during PAT with ayahuasca. Based on the results, this review aims to further expand the understanding of the role of music during psychedelic experiences and, if feasible, to provide an initial theoretical framework for the use of music in this context.

1.2. Review Question(s)

What is the use, role, and function of music in the context of PAT with ayahuasca?

1.3. Inclusion Criteria

1.3.1. Participants

Participants of PAT with ayahuasca. Our scope will not be limited to a specific population (i.e., there will be no restrictions based on age, gender, reason for assisting PAT, etc.). However, participant inclusion will be limited to those engaging in PAT sessions with ayahuasca in which music is used. Furthermore, we will only consider the literature in which participants orally ingested ayahuasca as a plant-based brew and will not consider synthetically extracted DMT that might be used vaporized or injected.

1.3.2. Concept

This review will consider studies that describe the use, role, and/or function of music in psychedelic therapy with ayahuasca. Music may include all types of musical genres, instruments, or chants, either presented live or recorded. Articles will be considered if they describe at least one of the following: the use (when, how, what) and/or the role (why, with what purpose) and/or the function (for what, directed towards what goal) of the music applied. An example hereof could be playing ethnic instrumental music at the beginning of the experience (use) as a facilitator for evoking imagery (role) to enhance openness or creativity in participants (function).

1.3.3. Context

This review will consider PAT studies with ayahuasca across all geographical regions. The overall scope of our study is global and will not be limited by time periods. While ayahuasca is used in different and, at times, overlapping contexts (e.g., ceremonial, entheogenic, therapeutic, etc.) and for many different reasons (e.g., for spiritual and personal growth, due to a medical condition, etc.), this scoping review will focus on ayahuasca during PAT and on contexts that are defined as ‘therapy’.

1.3.4. Types of Sources

This scoping review will consider quantitative, qualitative, and mixed-method study designs for inclusion. In addition, all types of literature reviews (i.e., narrative, systematic, etc.) will be considered for inclusion.

2. Methods

This scoping review will be conducted in accordance with the JBI methodology for scoping reviews [39] and is registered with the Open Science Framework database [40] (registration date: 2 October 2024. URL: https://doi.org/10.17605/OSF.IO/7GWS3). The final publication will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) [41]. Any changes to this protocol will be recorded to guarantee transparency and reproducibility.

2.1. Search Strategy

The search strategy will aim to locate any published primary studies, reviews, theses, and text and opinion papers. An initial and limited literature search was performed without year restrictions in English, Spanish, and Portuguese in the Web of Science, Scopus, Google Scholar, PubMed, SciELO, Dialnet, and Redalyc. The following keywords will be used for the English search: “Music” (additionally: “Singing”, “Chanting”, “Icaro”) AND “Ayahuasca”, “Music” AND “Yagé”, “Music” AND “DMT”, “Psychedelic therapy” AND (“music” AND “ayahuasca”), “Psychedelic therapy” AND (“music” AND “yagé”), and “Psychedelic therapy” AND (“music” AND “DMT”). The same keywords will be used in Spanish and Portuguese. An example of the full search strategy can be seen in Appendix A. Additionally, handsearching of reference lists of the included articles will be performed.

2.2. Study/Source of Evidence Selection

Following the search, all identified records will be matched and uploaded to Zotero 6.0, and duplicates will be removed. After a pilot test, titles and abstracts will be reviewed by two independent reviewers and checked against the review inclusion criteria. Potentially relevant articles will be retrieved as full text, and their citation details imported into the JBI System for Unified Management, Assessment, and Review of Information [42]. The full texts will then be assessed in detail against the inclusion criteria by two independent reviewers. Reasons for excluding full-text articles that do not meet the inclusion criteria will be recorded and reported in the final scoping review. Any disagreements that arise between reviewers at each stage of the screening process will be resolved by discussion or with a third reviewer. The results of the search results will be reported in the final scoping review and presented as a PRISMA flow diagram [43].

2.3. Data Extraction

Data extraction will be performed by two or more independent reviewers using an Excel data sheet developed by the authors. The data extracted from the full-text articles will include information about the article (e.g., author, year), type of article (e.g., research, review), population data (e.g., age, gender, participants), information about the use, role, and function of music (e.g., genre, song, live or recorded, goals for music use), data collection (e.g., interviews, questionnaires), and outcomes (e.g., statistical results, qualitative analysis, etc.). The data extraction tool will be modified and revised as necessary during the review process, and any modifications will be detailed in the scoping review. Any disagreements that arise between the reviewers will be resolved through discussion or by consulting an additional reviewer. If appropriate or required, authors of articles will be contacted to request missing or additional data.

2.4. Data Analysis and Presentation

Data will be presented in tabular form and as a narrative summary and synthesis. If feasible, an initial theoretical framework on the role, use, and function of music during PAT with ayahuasca will be outlined based on the extracted data. Possible indications for future research and/or clinical practice will be discussed.

2.5. Timeline

The scoping review is planned to take place throughout 2025 and is aimed to be completed during the first trimester of 2026. A final updated database search will take place on 1 March 2025.

2.6. Ethical Considerations

Ethical approval was not required as this study is based on the analysis of publicly available data. All sources used are cited according to copyright rules. The authors fully recognize and honor the cultural and spiritual heritage of ayahuasca medicine, as well as the custodianship of this practice by indigenous communities, their elders, and leaders. This project aims to raise awareness within the scientific community about the significance of the context in which ayahuasca is used, particularly the integral role of music, songs, and sounds. The authors firmly reject any forms of social or cultural appropriation of ancestral knowledge.

2.7. PRISMA Flow Diagram

Figure 1 shows the flow diagram of the search strategy, study selection, and assessment.

3. Conclusions

The conclusions drawn from this scoping review will highlight the importance of music as an integral component of PAT with ayahuasca and describe in detail the role, use, and function of music in such a setting. This is important not only for understanding how music might facilitate meaning and insights for participants but is also necessary considering the potential replicability of study designs. It is expected that this review will help to gain a deeper understanding of how musical elements contribute to the effectiveness of psychedelic-assisted therapy, and it is hoped that this approach will provide valuable insights for future research and clinical practices when including ayahuasca for therapeutic purposes.

Author Contributions

Conceptualization, G.E.-C., F.P.C., D.T., M.V. and M.E.; methodology, G.E.-C. and M.E.; writing—original draft preparation, G.E.-C. and M.E.; writing—review and editing, F.P.C., D.T. and M.V.; supervision, M.E.; project administration, M.E. All authors have read and agreed to the published version of the manuscript.

Funding

No external funding was received for this study.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data will be made available on request to the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A. Search Strategy

An example of the full search strategy is displayed below. We conducted the search in seven databases (Web of Science, Scopus, Google Scholar, PubMed, Rdalyc) on 14 October 2024, without any year restriction, in the English language. The search terms and Boolean functions were “Music” AND “Ayahuasca”, “Music” AND “Yagé”, “Music” AND “DMT”, “Psychedelic therapy” AND (“music” AND “ayahuasca”), “Psychedelic therapy” AND (“music” AND “yagé”), and “Psychedelic therapy” AND (“music” AND “DMT”).

Appendix A.1. Web of Science

Search conducted on 14 November 2024.
SearchQueryRecords Retrieved
#1(music) AND (ayahuasca)17
#2(music) AND (yage)1
#3(music) AND (dimethyltryptamine)5
#4((music) AND (ayahuasca)) AND (psychedelic therapy)5
#5((music) AND (yage)) AND (psychedelic therapy)0
#6((music) AND (dimethyltryptamine)) AND (psychedelic therapy)1
Search restricted to English, Spanish, and Portuguese languages, without year restriction.

Appendix A.2. Scopus

Search conducted on 14 November 2024.
SearchQueryRecords Retrieved
#1(music) AND (ayahuasca)15
#2(music) AND (yage)1
#3(music) AND (dimethyltryptamine)8
#4((music) AND (ayahuasca)) AND (psychedelic therapy)5
#5((music) AND (yage)) AND (psychedelic therapy)0
#6((music) AND (dimethyltryptamine)) AND (psychedelic therapy)1
Search restricted to English, Spanish, and Portuguese languages, without year restriction.

Appendix A.3. Google Scholar

Search conducted on 14 November 2024.
SearchQueryRecords Retrieved
#1(music) AND (ayahuasca)8030
#2(music) AND (yage)2850
#3(music) AND (dimethyltryptamine)15,600
#4((music) AND (ayahuasca)) AND (psychedelic therapy)2960
#5((music) AND (yage)) AND (psychedelic therapy)601
#6((music) AND (dimethyltryptamine)) AND (psychedelic therapy)3660
Search without language restriction; no year restriction.

Appendix A.4. PubMed

Search conducted on 14 November 2024.
SearchQueryRecords Retrieved
#1(music) AND (ayahuasca)9
#2(music) AND (yage)0
#3(music) AND (dimethyltryptamine)3
#4((music) AND (ayahuasca)) AND (psychedelic therapy)6
#5((music) AND (yage)) AND (psychedelic therapy)0
#6((music) AND (DMT)) AND (psychedelic therapy)1
Search restricted to English, Spanish, and Portuguese languages, without year restriction.

Appendix A.5. Redalyc

Search conducted on 14 November 2024.
SearchQueryRecords Retrieved
#1(music) AND (ayahuasca)149
#2(music) AND (yage)164
#3(music) AND (dimethyltryptamine)7
#4((music) AND (ayahuasca)) AND (psychedelic therapy)31
#5((music) AND (yage)) AND (psychedelic therapy)19
#6((music) AND (dimethyltryptamine)) AND (psychedelic therapy)6
Search restricted to English, Spanish, and Portuguese languages, without year restriction.

References

  1. Nichols, D.E. Psychedelics. Pharmacol. Rev. 2016, 68, 264–355. [Google Scholar] [CrossRef] [PubMed]
  2. Pollan, M. How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence; Penguin: London, UK, 2019. [Google Scholar]
  3. Strassman, R.J. Acid Dreams: The CIA, LSD, and the Sixties Rebellion; Storming Heaven: LSD and the American Dream. Am. J. Psychiatry 1989, 146, 395–396. [Google Scholar] [CrossRef]
  4. Bogenschutz, M.P.; Forcehimes, A.A.; Pommy, J.A.; Wilcox, C.E.; Barbosa, P.; Strassman, R.J. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. J. Psychopharmacol. 2015, 29, 289–299. [Google Scholar] [CrossRef] [PubMed]
  5. Ling, S.; Ceban, F.; Lui, L.M.W.; Lee, Y.; Teopiz, K.M.; Rodrigues, N.B.; Lipsitz, O.; Gill, H.; Subramaniapillai, M.; Mansur, R.B.; et al. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. CNS Drugs 2022, 36, 17–30. [Google Scholar] [CrossRef] [PubMed]
  6. Galvão-Coelho, N.L.; Marx, W.; Gonzalez, M.; Sinclair, J.; de Manincor, M.; Perkins, D.; Sarris, J. Classic serotonergic psychedelics for mood and depressive symptoms: A meta-analysis of mood disorder patients and healthy participants. Psychopharmacology 2021, 238, 341–354. [Google Scholar] [CrossRef]
  7. Ko, K.; Kopra, E.I.; Cleare, A.J.; Rucker, J.J. Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. J. Affect. Disord. 2023, 322, 194–204. [Google Scholar] [CrossRef]
  8. Reiff, C.M.; Richman, E.E.; Nemeroff, C.B.; Carpenter, L.L.; Widge, A.S.; Rodriguez, C.I.; Kalin, N.H.; McDonald, W.M. Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and psychedelic-assisted psychotherapy. Am. J. Psychiatry 2020, 177, 391–410. [Google Scholar] [CrossRef]
  9. Solmi, M.; Chen, C.; Daure, C.; Buot, A.; Ljuslin, M.; Verroust, V.; Mallet, L.; Khazaal, Y.; Rothen, S.; Thorens, G.; et al. A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs. Eur. Neuropsychopharmacol. 2022, 64, 44–60. [Google Scholar] [CrossRef]
  10. Brennan, W.; Belser, A.B. Models of psychedelic-assisted psychotherapy: A contemporary assessment and an introduction to EMBARK, a transdiagnostic, trans-drug model. Front. Psychol. 2022, 13, 866018. [Google Scholar] [CrossRef]
  11. Ruffell, S.; Netzband, N.; Bird, C.; Young, A.H.; Juruena, M.F. The pharmacological interaction of compounds in ayahuasca: A systematic review. Braz. J. Psychiatry 2020, 42, 646–656. [Google Scholar] [CrossRef]
  12. Ruffell, S.G.D.; Crosland-Wood, M.; Palmer, R.; Netzband, N.; Tsang, W.; Weiss, B.; Gandy, S.; Cowley-Court, T.; Halman, A.; McHerron, D.; et al. Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. Psychiatry Clin. Neurosci. Rep. 2023, 2, e146. [Google Scholar] [CrossRef] [PubMed]
  13. Bouso, J.C.; Andión, Ó.; Sarris, J.J.; Scheidegger, M.; Tófoli, L.F.; Opaleye, E.S.; Schubert, V.; Perkins, D. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob. Public. Health 2022, 2, e0000438. [Google Scholar] [CrossRef] [PubMed]
  14. Schultes, R.E. Hallucinogenic plants: Their earliest botanical descriptions. J. Psychedelic Drugs 1979, 11, 13–24. [Google Scholar] [CrossRef] [PubMed]
  15. Naranjo, P. Ayahuasca: Etnomedicina y Mitología; Ediciones Libri Mundi: Quito, Ecuador, 1983; p. 221. [Google Scholar]
  16. Schultes, R.E. The beta-carboline Hallucinogens of South America. J. Psychoact. Drugs 1982, 14, 205–220. [Google Scholar] [CrossRef]
  17. Metzner, R. (Ed.) Sacred Vine of Spirits: Ayahuasca; Inner Traditions/Bear & Co.: Rochester, VT, USA, 2005. [Google Scholar]
  18. Labate, B.C.; De Rose, I.S.; dos Santos, R.G. Ayahuasca Religions: A Comprehensive Bibliography and Critical Essays; Multidisciplinary Association for Psychedelic Studies: San Jose, CA, USA, 2008. [Google Scholar]
  19. Ayahuasca Global Consumption & Reported Deaths [Internet]. International Center for Ethnobotanical Education, Research, and Service (ICEERS). 2023. Available online: https://www.iceers.org/wp-content/uploads/ICEERS_Ayahuasca_deaths_en.pdf (accessed on 12 February 2025).
  20. Golden, T.L.; Magsamen, S.; Sandu, C.C.; Lin, S.; Roebuck, G.M.; Shi, K.M.; Barrett, F.S. Effects of setting on psychedelic experiences, therapies, and outcomes: A rapid scoping review of the literature. Disruptive Psychopharmacol. 2022, 56, 35–70. [Google Scholar]
  21. Kaelen, M.; Giribaldi, B.; Raine, J.; Evans, L.; Timmerman, C.; Rodriguez, N.; Roseman, L.; Feilding, A.; Nutt, D.; Carhart-Harris, R. The hidden therapist: Evidence for a central role of music in psychedelic therapy. Psychopharmacology 2018, 235, 505–519. [Google Scholar] [CrossRef]
  22. O’Callaghan, C.; Hubik, D.J.; Dwyer, J.; Williams, M.; Ross, M. Experience of music used with psychedelic therapy: A rapid review and implications. J. Music Ther. 2020, 57, 282–314. [Google Scholar] [CrossRef]
  23. Barrett, F.S.; Preller, K.H.; Kaelen, M. Psychedelics and music: Neuroscience and therapeutic implications. Int. Rev. Psychiatry 2018, 30, 350–362. [Google Scholar] [CrossRef]
  24. Chong, H.J.; Kim, H.J.; Kim, B. Scoping Review on the Use of Music for Emotion Regulation. Behav. Sci. 2024, 14, 793. [Google Scholar] [CrossRef]
  25. Peters, V.; Bissonnette, J.; Nadeau, D.; Gauthier-Legare, A.; Noel, M.A. The impact of musicking on emotion regulation: A systematic review and meta-analysis. Psychol. Music 2024, 52, 548–568. [Google Scholar] [CrossRef]
  26. Hou, J.; Song, B.; Chen, A.C.; Sun, C.; Zhou, J.; Zhu, H.; Beauchaine, T.P. Review on neural correlates of emotion regulation and music: Implications for emotion dysregulation. Front. Psychol. 2017, 8, 501. [Google Scholar] [CrossRef] [PubMed]
  27. Giove, R. Acerca del icaro, o canto shamanico. Rev. Takiwasi 1993, 2, 7–27. [Google Scholar]
  28. Hartogsohn, I. Set and setting in the Santo Daime. Front. Pharmacol. 2021, 12, 651037. [Google Scholar] [CrossRef] [PubMed]
  29. Rehen, L.K. Texto e contexto da música no santo daime: Algumas considerações sobre a noção de “eu”. Mana 2016, 22, 469–492. [Google Scholar] [CrossRef]
  30. Jerotic, K.; Vuust, P.; Kringelbach, M.L. Psychedelia: The interplay of music and psychedelics. Ann. N. Y. Acad. Sci. 2024, 1531, 12–28. [Google Scholar] [CrossRef]
  31. Efthimiou, A.A.; Cardinale, A.M.; Kepa, A. The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models. Psychedelic Med. 2024, 2, 221–233. [Google Scholar] [CrossRef]
  32. Shanon, B.; Clarke, D.; Clarke, E. Music and ayahuasca. In Music and Consciousness: Philosophical, Psychological, and Cultural Perspectives; Oxford University Press: New York, NY, USA, 2011; Volume 28, p. 281. [Google Scholar]
  33. Ecco, C.; Braga Reis, J.P. Music, Memory, Religion, and Ayahuasca: Musical Aspects and Religious Teachings in The Past and in Ayahuasca-based Religions in the Present. Religare 2022, 19, 48–73. [Google Scholar] [CrossRef]
  34. Campagnoli, A.P.; Pereira, L.A.; Bueno, J.L. Subjective time under altered states of consciousness in ayahuasca users in shamanistic rituals involving music. Braz. J. Med. Biol. Res. 2020, 53, e9278. [Google Scholar] [CrossRef]
  35. Sherwin, M.; Friso, F.; Fachner, J.; Politi, M. Participant experiences of icaros (Amazonian curative songs) during a traditional medicine ceremony at the Takiwasi Center, Peru. J. Psychedelic Stud. 2024. [Google Scholar] [CrossRef]
  36. Graham, O.J.; Saucedo, G.R.; Politi, M. Experiences of listening to icaros during ayahuasca ceremonies at centro takiwasi: An interpretive phenomenological analysis. Anthropol. Conscious. 2023, 34, 35–67. [Google Scholar] [CrossRef]
  37. Pollock, D.; Evans, C.; Jia, R.M.; Alexander, L.; Pieper, D.; de Moraes, É.B.; Peters, M.D.; Tricco, A.C.; Khalil, H.; Godfrey, C.M.; et al. ‘How-To’: Scoping Review? J. Clin. Epidemiol. 2024, 176, 111572. [Google Scholar] [CrossRef] [PubMed]
  38. Munn, Z.; Pollock, D.; Khalil, H.; Alexander, L.; Mclnerney, P.; Godfrey, C.M.; Peters, M.; Tricco, A.C. What are scoping reviews? Providing a formal definition of scoping reviews as a type of evidence synthesis. JBI Evid. Synth. 2022, 20, 950–952. [Google Scholar] [CrossRef] [PubMed]
  39. Peters, M.D.J.; Godfrey, C.; McInerney, P.; Munn, Z.; Tricco, A.C.; Khalil, H. Chapter 11: Scoping Reviews (2020 Version). In JBI Manual for Evidence Synthesis; Aromataris, E., Munn, Z., Eds.; JBI: Miami, FL, USA, 2020; Available online: https://synthesismanual.jbi.global (accessed on 12 February 2025). [CrossRef]
  40. Open Science Framework. Available online: https://doi.org/10.17605/OSF.IO/7GWS3 (accessed on 2 October 2024).
  41. Tricco, A.C.; Lillie, E.; Zarin, W.; O’Brien, K.K.; Colquhoun, H.; Levac, D.; Moher, D.; Peters, M.D.; Horsley, T.; Weeks, L.; et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann. Intern. Med. 2018, 169, 467–473. [Google Scholar] [CrossRef] [PubMed]
  42. Munn, Z.; Aromataris, E.; Tufanaru, C.; Stern, C.; Porritt, K.; Farrow, J. The development of software to support multiple systematic review types: The Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). Int. J. Evid. Based Healthc. 2019, 17, 36–43. [Google Scholar] [CrossRef]
  43. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Goffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
Figure 1. Search strategy using a PRISMA diagram.
Figure 1. Search strategy using a PRISMA diagram.
Psychoactives 04 00009 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Escobar-Cornejo, G.; Cardenas, F.P.; Torres, D.; Valderrama, M.; Ettenberger, M. The Use, Role, and Function of Music During Psychedelic-Assisted Therapy (PAT) with Ayahuasca: A Scoping Review Protocol. Psychoactives 2025, 4, 9. https://doi.org/10.3390/psychoactives4020009

AMA Style

Escobar-Cornejo G, Cardenas FP, Torres D, Valderrama M, Ettenberger M. The Use, Role, and Function of Music During Psychedelic-Assisted Therapy (PAT) with Ayahuasca: A Scoping Review Protocol. Psychoactives. 2025; 4(2):9. https://doi.org/10.3390/psychoactives4020009

Chicago/Turabian Style

Escobar-Cornejo, Guillermo, Fernando P. Cardenas, Diego Torres, Mario Valderrama, and Mark Ettenberger. 2025. "The Use, Role, and Function of Music During Psychedelic-Assisted Therapy (PAT) with Ayahuasca: A Scoping Review Protocol" Psychoactives 4, no. 2: 9. https://doi.org/10.3390/psychoactives4020009

APA Style

Escobar-Cornejo, G., Cardenas, F. P., Torres, D., Valderrama, M., & Ettenberger, M. (2025). The Use, Role, and Function of Music During Psychedelic-Assisted Therapy (PAT) with Ayahuasca: A Scoping Review Protocol. Psychoactives, 4(2), 9. https://doi.org/10.3390/psychoactives4020009

Article Metrics

Back to TopTop